Robert Stuver, MD, and Zachary D. Epstein-Peterson, MD, spoke with CancerNetwork® about a review article on the treatment of peripheral T-cell lymphoma published in the journal ONCOLOGY®.
Robert Stuver, MD, and Zachary D. Epstein-Peterson, MD, both of the Lymphoma Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, spoke with CancerNetwork® about their review published in the journal ONCOLOGY® titled Current Treatment of Peripheral T-cell Lymphoma.
In the article, Stuver and Epstein-Peterson explored current approaches to the diagnosis and treatment of peripheral T-cell lymphoma and novel emerging strategies clinicians who are practicing in the community should be aware of.
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma
November 3rd 2022Expert oncologist/hematologists Bruce Cheson, MD, FACP, and Steven Park, MD, discuss findings from the E7438-G000-101 trial and consider the efficacy of tazemetostat as treatment for relapsed or refractory follicular lymphoma.